AK
Anil Kumar Nandwani
About Anil Kumar Nandwani
Data last updated:
Anil Kumar Nandwani is a Director at Savitri Distributors Private Limited (since 2024), Director at Trilok Pharma Private Limited (since 2024) and Director at Global Institute Of Medical Science & Health Care (since 2011), and holds 5 more current directorships. The companies operate in Pharma, Healthcare and Real Estate and Construction. The 5 current companies with reported revenue have a combined latest revenue of ₹273 Cr; the largest is Savitri Distributors Private Limited at ₹199 Cr (FY 2025). Earlier, Anil Kumar Nandwani was a Director at Rajesh Specialities Private Limited (2020–2024) and Director at Samleshwari Pharma Private Limited (2021–2023) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Sep 2024 | 2023 | ₹199 Cr (FY 2025) | Active | |
| Director | 20 Sep 2024 | 2019 | ₹59.67 Cr (FY 2025) | Active | |
| Director | 08 Nov 2011 | 2011 | ₹10.18 Cr (FY 2024) | Active | |
| Director | 21 Feb 2012 | 2012 | ₹3.25 Cr (FY 2025) | Active | |
| Director | 05 Jul 2005 | 2000 | ₹85.9 Lakh (FY 2025) | Active | |
| Director | 10 Mar 2025 | 2025 | Active | ||
| Director | 09 Aug 2023 | 2023 | Active | ||
| Director | 03 Aug 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Aug 2020 | 2020 | ₹66.16 Cr (FY 2025) | Active | |
| Director | 23 Oct 2021 | 2021 | ₹8.77 Cr (FY 2024) | Active | |
| Director | 01 Apr 2002 | 2002 | Strike Off | ||
| Director | 18 Nov 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anil Kumar Nandwani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Nandwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Nandwani
Anil Kumar Nandwani currently holds 8 directorships: Savitri Distributors Private Limited (Director, since 20 Sep 2024, revenue ₹199 Cr (FY 2025)); Trilok Pharma Private Limited (Director, since 20 Sep 2024, revenue ₹59.67 Cr (FY 2025)); Global Institute Of Medical Science & Health Care (Director, since 08 Nov 2011, revenue ₹10.18 Cr (FY 2024)); Rabs Buildcon Private Limited (Director, since 21 Feb 2012, revenue ₹3.25 Cr (FY 2025)); Real Water Fun Private Limited (Director, since 05 Jul 2005, revenue ₹85.9 Lakh (FY 2025)); and 3 more.
Anil Kumar Nandwani was first appointed on 01 Apr 2002 as Director at Ethnotech Pharmaceuticals Private Limited. The most recent appointment on record is 10 Mar 2025 at Pushkar Infra Projects Private Limited.
The 5 current companies of Anil Kumar Nandwani that report revenue have a combined latest revenue of ₹273 Cr: Savitri Distributors Private Limited ₹199 Cr (FY 2025); Trilok Pharma Private Limited ₹59.67 Cr (FY 2025); Global Institute Of Medical Science & Health Care ₹10.18 Cr (FY 2024); Rabs Buildcon Private Limited ₹3.25 Cr (FY 2025); Real Water Fun Private Limited ₹85.9 Lakh (FY 2025).
Anil Kumar Nandwani held 4 earlier board appointments: Rajesh Specialities Private Limited (Director, 17 Aug 2020 to 21 Sep 2024); Samleshwari Pharma Private Limited (Director, 23 Oct 2021 to 18 Oct 2023); Ethnotech Pharmaceuticals Private Limited (Director, from 01 Apr 2002); Savitri Leela Private Limited (Director, from 18 Nov 2019).
The current boards of Anil Kumar Nandwani's companies include Manisha Nandwani (Savitri Distributors Private Limited), Manav Nandwani (Trilok Pharma Private Limited), Rajeev Baderia (Global Institute Of Medical Science & Health Care), Ritudwhaj Agrawal (Global Institute Of Medical Science & Health Care), Saurabh Baderia (Global Institute Of Medical Science & Health Care), Shobhit Baderia (Global Institute Of Medical Science & Health Care), among others.